ClinConnect ClinConnect Logo
Search / Trial NCT01856166

PIEB-PCEA Versus CEI-PCEA for Labor Analgesia in Nulliparous

Launched by UNIVERSITY HOSPITAL, MONTPELLIER · May 16, 2013

Trial Information

Current as of June 20, 2025

Completed

Keywords

Nulliparous Singleton Delivery Pregnancy

ClinConnect Summary

Patients will be informed during the anaesthetic consultation and recruited at the beginning of the labor if they comply with inclusion criteria. Habitual proceedings of the placing and induction of epidural analgesia (Local Anaesthetics (AL): Levobupivacaine 0.100% 15mL Sufentanil 10µg). Patients who will not obtain at 30min a pain score \< 1/10 will be excluded (epidural analgesia not functional). The upkeep of analgesia will be provided by an automatic pump and randomized in: classic pump and new pump. The mixture used will be the same in the 2 groups: Levobupivacaine 0.0100% + Sufentani...

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Nulliparous patient with a spontaneous labor at full term, from a normal pregnancy, carrier a singleton in cephalic position, with a distension \<4cm and eligible for an epidural analgesia
  • Patient has signed informed consent
  • Patient affiliated or beneficiary of a social medical insurance
  • Patient aged between 18 and 44 years old
  • Exclusion Criteria:
  • Morphinic administration before the care
  • Anomaly of fetal cardiac rate
  • Fetal or maternal anomalies wich don't allow to evaluate motor block
  • Known uterine malformation
  • Contraindications for thrusts for pregnancy
  • Patient protected by law
  • Patient under guardianship

About University Hospital, Montpellier

The University Hospital of Montpellier is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its commitment to patient-centered care, the hospital collaborates with multidisciplinary teams to explore cutting-edge treatments and therapies across various medical fields. By integrating clinical practice with education and research, the University Hospital of Montpellier aims to enhance health outcomes and contribute to the scientific community's understanding of complex medical conditions. Its robust infrastructure and expertise make it a pivotal player in the landscape of clinical research.

Locations

Bron, , France

Clermont Ferrand, , France

Le Kremlin Bicêtre, , France

Montpellier, , France

Patients applied

0 patients applied

Trial Officials

Estelle MORAU, PhD

Principal Investigator

CHU Montpellier - Department of gynaecology and obstetric

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials